Loading…
The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis
Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods...
Saved in:
Published in: | The Lancet infectious diseases 2013, Vol.13 (1), p.43-54 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563 |
---|---|
cites | cdi_FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563 |
container_end_page | 54 |
container_issue | 1 |
container_start_page | 43 |
container_title | The Lancet infectious diseases |
container_volume | 13 |
creator | Shallcross, Laura J, Dr Fragaszy, Ellen, MSc Johnson, Anne M, Prof Hayward, Andrew C, MD |
description | Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods We searched Medline and Embase for original research reporting the prevalence of PVL genes among Staphylococcus aureus pneumonia, bacteraemia, musculoskeletal infection, skin and soft-tissue infection, or colonisation published before Oct 1, 2011. We calculated odds ratios (ORs) to compare patients with PVL-positive colonisation and each infection relative to the odds of PVL-positive skin and soft-tissue infection. We did meta-analyses to estimate odds of infection or colonisation with a PVL-positive strain with fixed-effects or random-effects models, depending on the results of tests for heterogeneity. Results Of 509 articles identified by our search strategy, 76 studies from 31 countries met our inclusion criteria. PVL strains are strongly associated with skin and soft-tissue infections, but are comparatively rare in pneumonia (OR 0·37, 95% CI 0·22–0·63), musculoskeletal infections (0·44, 0·19–0·99), bacteraemias (0·10, 0·06–0·18), and colonising strains (0·07, 0·01–0·31). PVL-positive skin and soft-tissue infections are more likely to be treated surgically than are PVL-negative infections, and children with PVL-positive musculoskeletal disease might have increased morbidity. For other forms of disease we identified no evidence that PVL affects outcome. Interpretation PVL genes are consistently associated with skin and soft-tissue infections and are comparatively rare in invasive disease. This finding challenges the view that PVL mainly causes invasive disease with poor prognosis. Population-based studies are needed to define the role of PVL in mild, moderate, and severe disease and to inform control strategies. Funding None. |
doi_str_mv | 10.1016/S1473-3099(12)70238-4 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3530297</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1473309912702384</els_id><sourcerecordid>2844146791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563</originalsourceid><addsrcrecordid>eNqNkl1rFDEUhgdRbK3-BCUgQr0YzedkxouKFL-goGD1NmQyZ9zUTLIm2er-ezM7a6u9UQhJSJ7z5py8p6oeEvyMYNI8_0S4ZDXDXXdM6FOJKWtrfqs6LMe85lzI27v9ghxU91K6wJhIgvnd6oAyghmR9LCK5ytAMThAYUS57D9qn4Ovv2gHPlsPyMHGBGMH61EOP8tcRsp6vdq6UC6MdmiwCXSCF0ijtE0ZJp2tQREuLfxA2g9ogqxr7bXbJpvuV3dG7RI82K9H1ec3r89P39VnH96-P311VhvJSK6ZFKITvaHD0GqKzdCPHYxct2NHjJC4a4DyUeq-JaxpGiY60jeGSE4b2feiYUfVyaK73vQTDKbUE7VT62gnHbcqaKv-vvF2pb6GS8UEw7STReB4LxDD9w2krCabDDinPYRNUoS2onghWPsfaKmJUMq6gj6-gV6ETSx_M1Os46JgMyUWysSQUoTxKm-C1dwAatcAana3xKldAyhe4h79WfRV1G_HC_BkD-hUvBuj9sama66RtCVyTuDlwkGxqBgZVTIWvIHBRjBZDcH-M5WTGwrGWW_Lo99gC-m6apWowovIrFH-albg7BfZheJa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1239451229</pqid></control><display><type>article</type><title>The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</title><source>ScienceDirect Freedom Collection</source><creator>Shallcross, Laura J, Dr ; Fragaszy, Ellen, MSc ; Johnson, Anne M, Prof ; Hayward, Andrew C, MD</creator><creatorcontrib>Shallcross, Laura J, Dr ; Fragaszy, Ellen, MSc ; Johnson, Anne M, Prof ; Hayward, Andrew C, MD</creatorcontrib><description>Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods We searched Medline and Embase for original research reporting the prevalence of PVL genes among Staphylococcus aureus pneumonia, bacteraemia, musculoskeletal infection, skin and soft-tissue infection, or colonisation published before Oct 1, 2011. We calculated odds ratios (ORs) to compare patients with PVL-positive colonisation and each infection relative to the odds of PVL-positive skin and soft-tissue infection. We did meta-analyses to estimate odds of infection or colonisation with a PVL-positive strain with fixed-effects or random-effects models, depending on the results of tests for heterogeneity. Results Of 509 articles identified by our search strategy, 76 studies from 31 countries met our inclusion criteria. PVL strains are strongly associated with skin and soft-tissue infections, but are comparatively rare in pneumonia (OR 0·37, 95% CI 0·22–0·63), musculoskeletal infections (0·44, 0·19–0·99), bacteraemias (0·10, 0·06–0·18), and colonising strains (0·07, 0·01–0·31). PVL-positive skin and soft-tissue infections are more likely to be treated surgically than are PVL-negative infections, and children with PVL-positive musculoskeletal disease might have increased morbidity. For other forms of disease we identified no evidence that PVL affects outcome. Interpretation PVL genes are consistently associated with skin and soft-tissue infections and are comparatively rare in invasive disease. This finding challenges the view that PVL mainly causes invasive disease with poor prognosis. Population-based studies are needed to define the role of PVL in mild, moderate, and severe disease and to inform control strategies. Funding None.</description><identifier>ISSN: 1473-3099</identifier><identifier>ISSN: 1474-4457</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(12)70238-4</identifier><identifier>PMID: 23103172</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Bacteremia ; Bacterial diseases ; Bacterial Toxins - genetics ; Bacterial Toxins - metabolism ; Biological and medical sciences ; Children ; Colonization ; Exotoxins - genetics ; Exotoxins - metabolism ; Heterogeneity ; Human bacterial diseases ; Humans ; Infection ; Infectious Disease ; Infectious diseases ; Leukocidins - genetics ; Leukocidins - metabolism ; Medical sciences ; Morbidity ; Pneumonia ; Population studies ; Prognosis ; Reviews ; Skin ; Soft Tissue Infections - genetics ; Soft Tissue Infections - metabolism ; Soft Tissue Infections - microbiology ; Staphylococcal Infections - genetics ; Staphylococcal Infections - metabolism ; Staphylococcal Infections - microbiology ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Staphylococcal Skin Infections - genetics ; Staphylococcal Skin Infections - metabolism ; Staphylococcal Skin Infections - microbiology ; Staphylococcus aureus ; Staphylococcus aureus - genetics ; Staphylococcus aureus - metabolism ; Tissues ; Toxins</subject><ispartof>The Lancet infectious diseases, 2013, Vol.13 (1), p.43-54</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><rights>2013 Elsevier Ltd. All rights reserved. 2013 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563</citedby><cites>FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,4010,27904,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26728179$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23103172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shallcross, Laura J, Dr</creatorcontrib><creatorcontrib>Fragaszy, Ellen, MSc</creatorcontrib><creatorcontrib>Johnson, Anne M, Prof</creatorcontrib><creatorcontrib>Hayward, Andrew C, MD</creatorcontrib><title>The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods We searched Medline and Embase for original research reporting the prevalence of PVL genes among Staphylococcus aureus pneumonia, bacteraemia, musculoskeletal infection, skin and soft-tissue infection, or colonisation published before Oct 1, 2011. We calculated odds ratios (ORs) to compare patients with PVL-positive colonisation and each infection relative to the odds of PVL-positive skin and soft-tissue infection. We did meta-analyses to estimate odds of infection or colonisation with a PVL-positive strain with fixed-effects or random-effects models, depending on the results of tests for heterogeneity. Results Of 509 articles identified by our search strategy, 76 studies from 31 countries met our inclusion criteria. PVL strains are strongly associated with skin and soft-tissue infections, but are comparatively rare in pneumonia (OR 0·37, 95% CI 0·22–0·63), musculoskeletal infections (0·44, 0·19–0·99), bacteraemias (0·10, 0·06–0·18), and colonising strains (0·07, 0·01–0·31). PVL-positive skin and soft-tissue infections are more likely to be treated surgically than are PVL-negative infections, and children with PVL-positive musculoskeletal disease might have increased morbidity. For other forms of disease we identified no evidence that PVL affects outcome. Interpretation PVL genes are consistently associated with skin and soft-tissue infections and are comparatively rare in invasive disease. This finding challenges the view that PVL mainly causes invasive disease with poor prognosis. Population-based studies are needed to define the role of PVL in mild, moderate, and severe disease and to inform control strategies. Funding None.</description><subject>Bacteremia</subject><subject>Bacterial diseases</subject><subject>Bacterial Toxins - genetics</subject><subject>Bacterial Toxins - metabolism</subject><subject>Biological and medical sciences</subject><subject>Children</subject><subject>Colonization</subject><subject>Exotoxins - genetics</subject><subject>Exotoxins - metabolism</subject><subject>Heterogeneity</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infection</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Leukocidins - genetics</subject><subject>Leukocidins - metabolism</subject><subject>Medical sciences</subject><subject>Morbidity</subject><subject>Pneumonia</subject><subject>Population studies</subject><subject>Prognosis</subject><subject>Reviews</subject><subject>Skin</subject><subject>Soft Tissue Infections - genetics</subject><subject>Soft Tissue Infections - metabolism</subject><subject>Soft Tissue Infections - microbiology</subject><subject>Staphylococcal Infections - genetics</subject><subject>Staphylococcal Infections - metabolism</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Staphylococcal Skin Infections - genetics</subject><subject>Staphylococcal Skin Infections - metabolism</subject><subject>Staphylococcal Skin Infections - microbiology</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - genetics</subject><subject>Staphylococcus aureus - metabolism</subject><subject>Tissues</subject><subject>Toxins</subject><issn>1473-3099</issn><issn>1474-4457</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNkl1rFDEUhgdRbK3-BCUgQr0YzedkxouKFL-goGD1NmQyZ9zUTLIm2er-ezM7a6u9UQhJSJ7z5py8p6oeEvyMYNI8_0S4ZDXDXXdM6FOJKWtrfqs6LMe85lzI27v9ghxU91K6wJhIgvnd6oAyghmR9LCK5ytAMThAYUS57D9qn4Ovv2gHPlsPyMHGBGMH61EOP8tcRsp6vdq6UC6MdmiwCXSCF0ijtE0ZJp2tQREuLfxA2g9ogqxr7bXbJpvuV3dG7RI82K9H1ec3r89P39VnH96-P311VhvJSK6ZFKITvaHD0GqKzdCPHYxct2NHjJC4a4DyUeq-JaxpGiY60jeGSE4b2feiYUfVyaK73vQTDKbUE7VT62gnHbcqaKv-vvF2pb6GS8UEw7STReB4LxDD9w2krCabDDinPYRNUoS2onghWPsfaKmJUMq6gj6-gV6ETSx_M1Os46JgMyUWysSQUoTxKm-C1dwAatcAana3xKldAyhe4h79WfRV1G_HC_BkD-hUvBuj9sama66RtCVyTuDlwkGxqBgZVTIWvIHBRjBZDcH-M5WTGwrGWW_Lo99gC-m6apWowovIrFH-albg7BfZheJa</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Shallcross, Laura J, Dr</creator><creator>Fragaszy, Ellen, MSc</creator><creator>Johnson, Anne M, Prof</creator><creator>Hayward, Andrew C, MD</creator><general>Elsevier Ltd</general><general>Lancet Publishing Group</general><general>Elsevier Limited</general><general>Elsevier Science, The Lancet Pub. Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2013</creationdate><title>The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</title><author>Shallcross, Laura J, Dr ; Fragaszy, Ellen, MSc ; Johnson, Anne M, Prof ; Hayward, Andrew C, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Bacteremia</topic><topic>Bacterial diseases</topic><topic>Bacterial Toxins - genetics</topic><topic>Bacterial Toxins - metabolism</topic><topic>Biological and medical sciences</topic><topic>Children</topic><topic>Colonization</topic><topic>Exotoxins - genetics</topic><topic>Exotoxins - metabolism</topic><topic>Heterogeneity</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infection</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Leukocidins - genetics</topic><topic>Leukocidins - metabolism</topic><topic>Medical sciences</topic><topic>Morbidity</topic><topic>Pneumonia</topic><topic>Population studies</topic><topic>Prognosis</topic><topic>Reviews</topic><topic>Skin</topic><topic>Soft Tissue Infections - genetics</topic><topic>Soft Tissue Infections - metabolism</topic><topic>Soft Tissue Infections - microbiology</topic><topic>Staphylococcal Infections - genetics</topic><topic>Staphylococcal Infections - metabolism</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Staphylococcal Skin Infections - genetics</topic><topic>Staphylococcal Skin Infections - metabolism</topic><topic>Staphylococcal Skin Infections - microbiology</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - genetics</topic><topic>Staphylococcus aureus - metabolism</topic><topic>Tissues</topic><topic>Toxins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shallcross, Laura J, Dr</creatorcontrib><creatorcontrib>Fragaszy, Ellen, MSc</creatorcontrib><creatorcontrib>Johnson, Anne M, Prof</creatorcontrib><creatorcontrib>Hayward, Andrew C, MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shallcross, Laura J, Dr</au><au>Fragaszy, Ellen, MSc</au><au>Johnson, Anne M, Prof</au><au>Hayward, Andrew C, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2013</date><risdate>2013</risdate><volume>13</volume><issue>1</issue><spage>43</spage><epage>54</epage><pages>43-54</pages><issn>1473-3099</issn><issn>1474-4457</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods We searched Medline and Embase for original research reporting the prevalence of PVL genes among Staphylococcus aureus pneumonia, bacteraemia, musculoskeletal infection, skin and soft-tissue infection, or colonisation published before Oct 1, 2011. We calculated odds ratios (ORs) to compare patients with PVL-positive colonisation and each infection relative to the odds of PVL-positive skin and soft-tissue infection. We did meta-analyses to estimate odds of infection or colonisation with a PVL-positive strain with fixed-effects or random-effects models, depending on the results of tests for heterogeneity. Results Of 509 articles identified by our search strategy, 76 studies from 31 countries met our inclusion criteria. PVL strains are strongly associated with skin and soft-tissue infections, but are comparatively rare in pneumonia (OR 0·37, 95% CI 0·22–0·63), musculoskeletal infections (0·44, 0·19–0·99), bacteraemias (0·10, 0·06–0·18), and colonising strains (0·07, 0·01–0·31). PVL-positive skin and soft-tissue infections are more likely to be treated surgically than are PVL-negative infections, and children with PVL-positive musculoskeletal disease might have increased morbidity. For other forms of disease we identified no evidence that PVL affects outcome. Interpretation PVL genes are consistently associated with skin and soft-tissue infections and are comparatively rare in invasive disease. This finding challenges the view that PVL mainly causes invasive disease with poor prognosis. Population-based studies are needed to define the role of PVL in mild, moderate, and severe disease and to inform control strategies. Funding None.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>23103172</pmid><doi>10.1016/S1473-3099(12)70238-4</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1473-3099 |
ispartof | The Lancet infectious diseases, 2013, Vol.13 (1), p.43-54 |
issn | 1473-3099 1474-4457 1474-4457 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3530297 |
source | ScienceDirect Freedom Collection |
subjects | Bacteremia Bacterial diseases Bacterial Toxins - genetics Bacterial Toxins - metabolism Biological and medical sciences Children Colonization Exotoxins - genetics Exotoxins - metabolism Heterogeneity Human bacterial diseases Humans Infection Infectious Disease Infectious diseases Leukocidins - genetics Leukocidins - metabolism Medical sciences Morbidity Pneumonia Population studies Prognosis Reviews Skin Soft Tissue Infections - genetics Soft Tissue Infections - metabolism Soft Tissue Infections - microbiology Staphylococcal Infections - genetics Staphylococcal Infections - metabolism Staphylococcal Infections - microbiology Staphylococcal infections, streptococcal infections, pneumococcal infections Staphylococcal Skin Infections - genetics Staphylococcal Skin Infections - metabolism Staphylococcal Skin Infections - microbiology Staphylococcus aureus Staphylococcus aureus - genetics Staphylococcus aureus - metabolism Tissues Toxins |
title | The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T07%3A46%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20the%20Panton-Valentine%20leucocidin%20toxin%20in%20staphylococcal%20disease:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Shallcross,%20Laura%20J,%20Dr&rft.date=2013&rft.volume=13&rft.issue=1&rft.spage=43&rft.epage=54&rft.pages=43-54&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(12)70238-4&rft_dat=%3Cproquest_pubme%3E2844146791%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1239451229&rft_id=info:pmid/23103172&rfr_iscdi=true |